Mint Med Review: Following the Care Path From Checkout to Pharmacy Delivery

With Mint Med, the important question is not simply what a monthly plan costs. It is who takes responsibility at each handoff: the platform collecting information and payment, the clinician deciding whether to prescribe, the pharmacy dispensing medication and the team answering questions afterward. Mint Med describes those roles, but its public documentation does not always give one consistent account of how a patient moves between them. That makes the checkout terms and the actual pharmacy assignment especially important.

This documentary review examines Mint Med’s public pages consulted October 19, 2026. The business advertises compounded semaglutide and tirzepatide through recurring monthly and prepaid plans, subject to clinical approval. It also documents secure messaging, home delivery and named pharmacy partners. The useful starting point is its care structure—not an assumption that one advertised price, review deadline or shipping promise applies to every enrollment route. Our guide to the care journey explains how these separate stages fit together.

At a glance

Who provides medical care: Mint Med’s terms describe MINT MED, LLC as a platform connecting patients with independent licensed providers, rather than the entity delivering medical services.
Sources: [10]
Documented medicines: Product pages advertise compounded semaglutide and compounded tirzepatide. The semaglutide page documents injection supplies; the reviewed material does not clearly establish the tirzepatide route.
Sources: [6] [14]
Different price paths: Semaglutide appears at $89 monthly on one page and $129 monthly on another; intake lists starting prices of $106 monthly for semaglutide and $145 for tirzepatide.
Sources: [13] [6] [7]
Pharmacy responsibility: Mint Med says it does not manufacture, compound or dispense medication. Its contact page names RxCompoundStore Pharmacy and Southend Pharmacy as fulfillment partners.
Sources: [6] [12]
Cancellation deadline: The formal policy requires the official cancellation form at least 48 business hours before scheduled order processing and excludes refunds once an order has been processed.
Sources: [5]

Start by identifying the platform, clinician and service area

Mint Med describes itself as a fully online telehealth platform covering weight loss, energy and wellness, sexual wellness and hair regrowth. Its terms assign medical services to independent licensed providers in the patient’s state and say the platform itself does not create a physician-patient relationship. The institutional page names Roderick Huff, MD, as founder and attributes more than two decades of experience to him. Those are provider statements, not independently verified credentials in this review.

The legal identity also needs clarification. The terms name MINT MED, LLC, while the privacy policy names Glow Medispa, LLC doing business as Mint Med. The consulted documentation does not explain their relationship. For patients, that distinction matters when identifying who holds information, who handles administrative disputes and which organization is responsible for clinical care. Our explanation of clinician and platform responsibilities provides context without treating the two roles as interchangeable.

Eligibility is geographically limited: the terms require U.S. residence, presence in an operating state and age 18 or older, with some services potentially requiring age 21 or older. The homepage says 35 states but lists 36 abbreviations, including California; the contact page lists 35 without California. A California applicant therefore needs direct confirmation rather than relying on either list alone. The documentation reviewed here does not establish international care availability.

Sources: [10] [15] [9] [11] [12]

Intake is a clinical handoff, not an automatic prescription

Mint Med’s intake asks about symptoms, medical history and health goals before recommendations are made. It also asks about GLP-1 use during the preceding two months. Ozempic, Wegovy, Zepbound and Mounjaro appear as examples in that history question; their presence does not establish that Mint Med sells those branded products. The form additionally asks about gastrointestinal conditions, pancreatic history, diabetes, thyroid cancer, MEN-2 and eating disorders. These are documented screening questions, not a complete published eligibility standard.

The consultation format depends on state requirements. Mint Med says patients may be prompted to schedule live audio or video; where asynchronous care is permitted, a provider reviews the chart and sends a recommendation to the secure patient inbox. The intake claims every case receives review by a U.S. physician board-certified in obesity medicine, but that claim was not independently verified. Elsewhere, the site uses broader terms such as licensed clinician or provider.

One semaglutide page says portal access and the medical questionnaire arrive by email after payment, with the questionnaire estimated to take three to five minutes. That completion estimate is not a clinical review deadline. The consulted pages do not clearly specify BMI thresholds, laboratory requirements or a mandatory follow-up schedule. Applicants should establish what information is required, whether a live visit is necessary and how unanswered clinical questions will be resolved before assuming that checkout completes the consultation.

Sources: [7] [9] [6]

Resolve the payment route before entering the review queue

Payment timing is unresolved across Mint Med’s pages. The homepage says payment is collected upfront to begin clinical review, with medication prescribed only if medically appropriate. A product section instead offers a free, no-obligation evaluation and says payment is processed only after provider approval. These statements describe materially different entry points. Ask whether the transaction is an immediate charge or another payment arrangement, which terms govern that checkout and what happens if additional information delays the decision.

Prices also differ by page. The table captures the lower-priced dedicated product listings, not a universal quote. Another semaglutide page advertises $129 billed month to month, plus prepaid options advertised at $119 per month for three months or $109 per month for six months. The three-month option expressly describes a three-month supply. Separately, intake advertises semaglutide starting at $106 monthly and tirzepatide starting at $145 monthly without explaining the associated commitment there.

The listings advertise lifetime pricing and all dose levels included, but the full boundaries of that promise are not clear. The $129 semaglutide page includes medication if prescribed, injection supplies, two-day cold shipping and clinician visits, with no separate membership, access or clinician-visit fee. The homepage lists intake review, eligibility assessment, a visit if needed, unlimited messaging and ongoing support. Terms nevertheless make services cash-pay, reject insurance and assign third-party costs to the patient.

Selected advertised compounded-medication plans; other pages show different prices. These listings advertise lifetime pricing and all dose levels included.
Compounded medication	Monthly billing option	Prepaid alternatives
Semaglutide	$89 billed every month; delivery monthly	$85/month equivalent; $255 billed every 3 months
Semaglutide	Same $89 monthly listing	$79/month equivalent; $474 billed every 6 months
Tirzepatide	$119 billed every month; delivery monthly	$110/month equivalent; $330 billed every 3 months
Tirzepatide	Same $119 monthly listing	$99/month equivalent; $594 billed every 6 months

Sources: [13] [14] [6] [7] [9] [10]

Approval starts another clock rather than ending the process

Mint Med publishes several clinical-review expectations. Its how-it-works page says a licensed provider reviews intake within six business hours and contacts the patient directly if questions arise. A product section refers to review within 24 business hours and normally same-day approvals. Another passage says review normally occurs within 48 business hours and explicitly notes that timing can vary. These should not be collapsed into a single reliable turnaround promise for every applicant.

After approval, the homepage describes prescription processing within 24–48 business hours and shipping typically taking five to seven business days. Elsewhere, the $129 semaglutide offering includes two-day cold shipping, while another product passage advertises free overnight shipping once approved. A shipping service level is not the same as elapsed time from payment to arrival. The public pages do not reconcile which fulfillment timeline belongs to each enrollment route or pharmacy.

The intake says an approved prescription is shipped cold-packed to the listed address, with no in-person collection, and tracking becomes available only after the pharmacy ships. That gives patients a useful milestone: approval without tracking does not establish dispatch. Before paying, ask which review estimate, processing stage and transit service apply to the selected plan. Our delivery-timing guide explains why these separate clocks should not be added or substituted casually.

Sources: [8] [6] [9] [7]

The pharmacy determines what is actually dispensed

Mint Med expressly says it coordinates care but does not manufacture, compound or dispense medication. It also warns that the dispensing pharmacy, formulation, concentration, packaging and labeling may vary. The contact page names RxCompoundStore Pharmacy in Fort Lauderdale, Florida, and Southend Pharmacy in Houston, Texas, as fulfillment partners. Naming partners is useful documentation, but it does not establish which pharmacy will handle an individual prescription or independently verify licensing, accreditation or current inventory.

The semaglutide offering documents an injectable presentation through its inclusion of injection supplies. The consulted material does not clearly specify the tirzepatide route or each pharmacy’s exact formulation. Patients therefore need the actual prescription and dispensing label, not just an ingredient name and advertised monthly price. Our pharmacy-handoff questions focus on confirming the dispenser, product and instructions. Nothing in this review establishes use of a particular salt form or other unlisted ingredient.

FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that alone does not prove clinical inequivalence. FDA also explicitly advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy to resolve the concern.

Sources: [6] [12] [9] [1]

Follow-up has a documented channel, but not a clear schedule

Mint Med’s homepage includes unlimited care-team messaging and ongoing support in its description of what payment covers. Intake directs medical questions, dosing questions, billing, address changes and support to the Elation Health Patient Portal. It expressly says Facebook and Instagram are not secure medical-support channels and do not have access to pharmacy shipping information. That is a meaningful operational boundary: a social-media exchange should not be treated as a substitute for the documented patient-support route.

For general contact, Mint Med publishes telephone and text support at +1-513-826-6142 and email at help@mintmed.com. Its contact page lists Monday through Friday, 9 a.m.–5 p.m. EST. Those hours do not establish immediate clinical response, overnight staffing or an emergency service. The consulted pages also do not establish how often clinicians proactively check in, who reviews messages between scheduled visits or whether the same clinician remains responsible throughout treatment.

This missing schedule matters more than the word “unlimited.” NIDDK describes follow-up as evaluating tolerance and response, not merely continuing payments, and recommends discussing health conditions, other medicines, supplements and pregnancy plans with the clinician. Mint Med applicants can ask how those reviews occur within the included service. The documentation also does not confirm Spanish-language care, translated consent or interpreter availability, so patients needing those services should verify them before enrollment.

Sources: [9] [7] [12] [2]

Renewal and cancellation are part of the care transition

Mint Med’s intake agreement says plans automatically renew at the checkout price and interval until canceled. It permits cancellation through the account or by email up to 48 business hours before renewal. The formal cancellation policy instead requires the official cancellation form and receipt at least 48 business hours before scheduled order processing. It says requests within that window cannot be honored. These are different channels and potentially different reference dates, so obtaining written confirmation is important.

The formal policy also adds a financial condition for prepaid subscriptions of three, six or twelve months: cancellation before completing the prepaid term requires payment of the difference between promotional and full pricing. That policy should not be confused with a simple promise that unused months are refundable. Nor does a package’s duration, by itself, establish medication quantity. Ask how the adjustment is calculated for the exact plan and whether stopping future renewals affects an already processed order.

Refund boundaries are tied to processing rather than shipment. The policy excludes refunds after an order is processed, even if it has not shipped, and does not accept returns once a prescription has been filled and dispensed. Consultation fees become nonrefundable after a provider visit unless the provider determines medical ineligibility. Although another page promises an immediate full refund for ineligibility, it does not establish when funds will appear in the patient’s bank account.

Sources: [7] [5] [8]

What to obtain in writing before choosing a plan

A useful enrollment confirmation would identify the applicable legal entity, clinician arrangement, state availability, exact compounded product, assigned pharmacy and final checkout price. It should also distinguish the first charge from later renewals and state which review and shipping expectations apply. Mint Med documents pieces of this pathway, but its conflicting pages make a single saved checkout summary more useful than relying on a homepage slogan. Confirmation still would not guarantee a prescription or an individual outcome.

The conversation should include alternatives and service boundaries. Mint Med also advertises a customizable non-GLP-1 MintFit Weight Loss Kit that may include low-dose naltrexone, bupropion, metformin ER, inositol or orlistat depending on clinical needs. This establishes a broader offering, not that any particular alternative is appropriate for an applicant. Similarly, clinical studies of semaglutide or tirzepatide do not establish outcomes for Mint Med, its compounded preparations or a particular patient.

Sources: [10] [6] [7] [3] [4]

Questions & answers

Does Mint Med itself prescribe and dispense the medication?

Its terms separate those responsibilities. Mint Med provides the platform, independent licensed providers deliver medical services, and partner pharmacies dispense medication. The company specifically says it does not manufacture, compound or dispense. Ask which clinician and pharmacy are assigned to your case rather than treating the Mint Med name as identifying every organization involved.

Sources: [10] [6]

Which Mint Med semaglutide price should I expect?

There is no single price consistently documented across the consulted pages. One listing offers $89 billed monthly; another offers $129 billed month to month; intake says starting at $106 monthly. Prepaid alternatives also differ. Confirm the medication, billing interval, amount collected, included services and renewal terms shown in your own checkout before authorizing payment.

Sources: [13] [6] [7]

Will I need a video visit?

Possibly. Mint Med says state requirements determine whether live video or audio is needed. Where asynchronous care is allowed, the provider can review the chart and send a recommendation through secure patient chat. The documentation does not establish that every applicant qualifies for an entirely message-based consultation or that completing intake guarantees approval.

Sources: [9]

How soon will medication arrive after approval?

The public pages do not provide one consistent answer. They describe prescription processing, five-to-seven-business-day shipping, two-day cold shipping and an overnight-shipping offer in different places. Intake says tracking appears only after the pharmacy ships. Ask for the assigned pharmacy’s processing estimate and transit service separately; approval is not evidence that the package has already been dispatched.

Sources: [9] [6] [7]

Where should an enrolled patient send questions?

Intake directs medical, billing, address-change and support questions to the Elation Health Patient Portal. General contact is available by call or text at +1-513-826-6142 or email at help@mintmed.com, with published weekday hours of 9 a.m.–5 p.m. EST. Mint Med specifically warns that Facebook and Instagram are not secure medical-support channels.

Sources: [7] [12]

Can I cancel before shipping and receive a refund?

Not necessarily. Mint Med’s formal policy excludes refunds once an order has been processed, whether or not it has shipped. It requires cancellation through the official form at least 48 business hours before scheduled processing. Prepaid cancellations may also trigger a promotional-price adjustment. Cancellation of future renewals and refund eligibility for an existing order are separate questions.

Sources: [5]

Our assessment

Mint Med documents a recognizable online care pathway: medical intake, independent clinical review, partner-pharmacy fulfillment, cold-packed home delivery and portal-based support. Its named pharmacy partners and explicit separation of platform and dispensing roles are useful disclosures. The main limitation is consistency. Prices, charge timing, geographic coverage, review windows, shipping promises and cancellation channels differ across public pages. A prospective patient would benefit from a written, plan-specific explanation before payment, particularly for prepaid enrollment. The documentation supports describing an available care model, not verifying every operational promise, professional credential or treatment outcome. Whether that model meets a patient’s needs depends on the actual clinician relationship, dispensed product and follow-up arrangements—not the advertised monthly figure alone.

Visit Mint Med’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Mint Med Review: Following the Care Path From Checkout to Pharmacy Delivery

At a glance

01Start by identifying the platform, clinician and service area

02Intake is a clinical handoff, not an automatic prescription

03Resolve the payment route before entering the review queue

04Approval starts another clock rather than ending the process

05The pharmacy determines what is actually dispensed

06Follow-up has a documented channel, but not a clear schedule

07Renewal and cancellation are part of the care transition

08What to obtain in writing before choosing a plan